Last reviewed: June 16, 2026

Last updated: June 16, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide is a GLP-1 receptor agonist medication that helps people lose weight by reducing appetite and improving blood sugar control. In clinical trials, patients using semaglutide lost an average of 15-22% of their body weight over 68 weeks. PlexusDx makes this proven treatment accessible through compounded injections at flat monthly pricing starting at $149.

How Semaglutide Triggers Weight Loss at the Cellular Level

Semaglutide binds to GLP-1 receptors in your brain, pancreas, and gut. This activation slows stomach emptying, which keeps you feeling full longer after eating. The medication also increases signals that tell your brain you've had enough food, naturally lowering your appetite without requiring willpower alone.

Beyond appetite control, semaglutide stabilizes blood sugar by stimulating insulin release when glucose is high. This prevents the energy crashes that trigger cravings and overeating. By addressing both hunger hormones and metabolic regulation, semaglutide creates multiple pathways to sustainable weight loss.

Clinical Evidence Behind Semaglutide's Weight Loss Results

The STEP trials, which followed over 4,500 patients for nearly 18 months, showed that semaglutide combined with lifestyle changes produced average weight loss of 15-22% of starting body weight. Patients receiving the highest dose lost significantly more weight than those on placebo, with benefits sustained over the full study period.

These results are not temporary. Research shows that people who maintain semaglutide treatment continue losing weight and prevent regain, unlike dieting alone where most people regain weight within 1-2 years. This durability makes semaglutide effective for long-term weight management.

Why Compounded Semaglutide from PlexusDx Makes Access Easier

PlexusDx sources all semaglutide from licensed 503A compounding pharmacies, ensuring pharmaceutical-grade quality without the brand name cost. Starting at $149 per month, compounded semaglutide is substantially less expensive than branded Ozempic or Wegovy while containing the same active ingredient.

Because PlexusDx works with patients directly instead of insurance companies, there are no prior authorization delays, no membership fees, and no coverage denials. The medication ships to all 50 states, and HSA and FSA accounts can be used for payment, making it practical for most budgets.

Personalized Dosing and Genetic Insights for Your GLP-1 Response

Not everyone responds to semaglutide the same way. Your GLP-1 receptor genetics, FTO gene variant, and other peptide pathways influence how effectively the medication works for your body. PlexusDx offers the Precision Peptide Genetic Test ($99 after your first month) to map 49 peptides across 14 metabolic pathways and identify your genetic predispositions.

This testing can reveal whether your body is optimized for semaglutide monotherapy or whether a dual-compound approach like GLP-Squared (semaglutide plus tirzepatide) may unlock better results. Your genetic profile also guides the starting dose and titration pace that produces the fastest sustainable weight loss with fewest side effects.

Managing Expectations and Common Side Effects

Most people experience nausea, especially when starting semaglutide or increasing doses. This typically resolves within 1-2 weeks as your body adapts. Some patients report reduced appetite for foods they previously enjoyed, constipation, or mild fatigue—all manageable with dose adjustments and lifestyle changes like increased hydration and fiber.

Serious side effects are rare but possible, including pancreatitis, gallbladder issues, and thyroid concerns in those with personal or family history of medullary thyroid cancer. PlexusDx screens for these contraindications during intake and monitors your progress monthly to catch any issues early.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

How quickly will I see weight loss results with semaglutide?

Most patients notice reduced hunger within 1-2 weeks and measurable weight loss by week 4-6. Significant weight loss (5-10% of body weight) typically occurs within 8-12 weeks of consistent use. Results accelerate as you reach higher therapeutic doses over the titration phase.

Is compounded semaglutide as safe and effective as brand-name Ozempic or Wegovy?

Yes. PlexusDx's semaglutide comes from licensed 503A compounding pharmacies that must meet the same pharmaceutical standards as manufacturers. The active ingredient is identical; the difference is cost and accessibility. Clinical efficacy depends on the medication itself, not the brand.

What is included in the PlexusDx Precision Peptide Genetic Test?

The test examines 14 metabolic pathways and 49 peptides to identify genetic variants affecting GLP-1 receptor sensitivity, appetite regulation, and fat metabolism. Key markers include GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313. Results guide whether semaglutide alone or a dual compound is optimal for your genetics.

Can I use my HSA or FSA with PlexusDx semaglutide?

Yes. PlexusDx medications are HSA and FSA eligible, allowing you to pay with pre-tax health savings. Compounded semaglutide starting at $149 per month is typically affordable even without insurance, and these accounts make it even more cost-effective.

What happens if semaglutide alone isn't enough for my weight loss goals?

PlexusDx offers GLP-Squared, a dual-compound injection combining semaglutide and tirzepatide, starting at $249 per month. This combination targets multiple appetite and metabolism pathways and often produces superior results for patients who plateau on monotherapy. Your Precision Peptide Genetic Test can help predict which approach suits your genetics best.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves